Cell Therapy News Volume 11.35 | Sep 13 2010

    0
    34
    Cell Therapy News 11.35, September 13, 2010.
    In this issue:  Science  |  Policy  |  Business  |  NIH  |  CBER  |  Regulatory  |  Events Subscribe  |  Unsubscribe

    TOP STORY  

    Researchers Illuminate Operation of Molecular Gateway to the Cell Nucleus
    Biophysicists have traced with unprecedented resolution the paths of cargos moving through the nuclear pore complex, a selective nanoscale aperture that controls access to the cell’s nucleus, and answered several key questions about its function. [Press release from the California Institute for Quantitative Biosciences discussing online prepublication in Nature]

    MethoCult® 
    MethoCult®
    The most published medium for hematopoietic CFC assays

    by STEMCELL Technologies
     
     
    TEST YOUR COLONY IDENTIFICATION SKILLSSTEMCELL Technologies Inc
     


    SPECIAL FEATURE


    Complimentary Webinar Presented by STEMCELL Technologies: EPO and Erythropoiesis, Detecting Lineage Commitment



    SCIENCE NEWS

    Researchers Uncover New Ovarian Cancer Gene (A Connection Between Cancer and Endometriosis)
    Researchers reveal a major new cancer gene – ARID1A. Mutations are frequent in this gene and link two types of ovarian cancer to endometriosis. [Press release from the British Columbia Cancer Agency discussing online prepublication in the New England Journal of Medicine]

    Twins Help Researchers to Find Genes for Blindness
    Using data collected from over 1,000 sets of twins, research has uncovered genes that affect eyesight as part of several conditions. Researchers discovered a new gene for myopia and new genes affecting glaucoma risk. [Press release from the Queensland Institute of Medical Research discussing online prepublication in Nature Genetics]

    Lung Cancer Culprit Could Offer Target for Therapy
    A tiny molecule that spurs the progression of non-small-cell lung cancer could become a player in fighting the disease, say researchers. [Press release from the University of Texas Southwestern Medical Center discussing online prepublication in Cancer Cell]

    Biologists Find Way to Reduce Stem Cell Loss During Cancer Treatment
    Biologists have discovered that a gene critical for programmed cell death is also important in the loss of adult stem cells, a finding that could help to improve the health and well-being of patients undergoing cancer treatment. [Press release from the University of California, San Diego discussing online prepublication in Nature Cell Biology]

    How Physical Environment Influences Stem Cell Development
    Recent research has revealed how physical qualities — and not only chemical ones — may have an influence in determining how adult stem cells from the bone marrow develop into differentiated ones. [Press release from ScienceDaily discussing online prepublication in Nature Physics]

    Scientist Identifies New Gene for Memory
    A scientist has for the first time identified a new gene that is required for memory formation in Drosophila. [Press release from the Scripps Research Institute discussing online prepublication in Neuron]

    With HMGB1's Help, Cells Dine In
    A team led by researchers at the University of Pittsburgh Cancer Institute discovered a link between autophagy and the protein HMGB1. [Press release from EurekAlert! discussing online prepublication in the Journal of Cell Biology]

    Scientists Create New Process to “Program” Cancer Cell Death
    Researchers have engineered a fundamentally new approach to killing cancer cells. The process uses small RNA molecules that can be programmed to attack only specific cancer cells; then, by changing shape, those molecules cause the cancer cells to self-destruct. [Press release from the California Institute of Technology discussing online prepublication in the Proceedings of the National Academy of Sciences USA]

    Cloud Computing Method Greatly Increases Gene Analysis
    Researchers have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. [Press release from the Johns Hopkins Bloomberg School of Public Health discussing online prepublication in Genome Biology]

    Regenerative Cellular Therapy in Chronic Kidney Disease Extends Survival
    Rodents with chronic kidney disease were treated with healthy kidney cells to catalyze the regeneration of functional kidney tissue and delay disease progression, as evidenced by extended survival, improved kidney filtration, and reduced severity of kidney tissue pathology. [Press release from Tengion, Inc. discussing online prepublication in the American Journal of Physiology Renal Physiology]

    Third Generation Map of Human Genetic Variation Published
    An international consortium today published a third-generation map of human genetic variation, called the HapMap, which includes data from an additional seven global populations, increasing the total number to 11 populations. [National Institutes of Health Press Release]

    UCSF Unveils Model for Implantable Artificial Kidney to Replace Dialysis
    Researchers unveiled a prototype model of the first implantable artificial kidney, in a development that one day could eliminate the need for dialysis. [University of California, San Francisco Press Release]

    CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

    ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
    Data implicate ARID1A as a tumor-suppressor gene frequently disrupted in ovarian clear-cell and endometrioid carcinomas. Since ARID1A mutation and loss of BAF250a can be seen in the preneoplastic lesions, researchers speculate that this is an early event in the transformation of endometriosis into cancer. [N Engl J Med]

    Selectivity Mechanism of the Nuclear Pore Complex Characterized by Single Cargo Tracking
    Researchers show that import proceeds by successive substeps comprising cargo capture, filtering and translocation, and release into the nucleus. [Nature]

    A Genome-Wide Association Study Identifies a Susceptibility Locus for Refractive Errors and Myopia at 15q14
    Data suggest that common variants at 15q14 influence susceptibility for refractive errors in the general population. [Nat Genet]

    Common Variants Near CAV1 and CAV2 are Associated with Primary Open-Angle Glaucoma
    The risk variant identified here is located close to CAV1 and CAV2, both of which are expressed in the trabecular meshwork and retinal ganglion cells that are involved in the pathogenesis of primary open-angle glaucoma. [Nat Genet]

    Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
    Researchers show that overexpression of MicroRNA-21 (miR-21) enhances tumorigenesis and that genetic deletion of miR-21 partially protects against tumor formation. [Cancer Cell]

    Puma Is Required for p53-Induced Depletion of Adult Stem Cells
    Findings suggest a key role of p53-dependent apoptosis in depleting adult stem cells after the accumulation of DNA damage, which leads to a decrease in tissue regeneration. [Nat Cell Biol]

    Optimal Matrix Rigidity for Stress-Fiber Polarization in Stem Cells
    Researchers present a theoretical model and experiments demonstrating that the alignment of stress fibers within stem cells is a non-monotonic function of matrix rigidity. [Nat Phys]

    Gilgamesh Is Required for rutabaga-Independent Olfactory Learning in Drosophila
    Researchers identified alleles of the gilgamesh (gish) gene, which encodes a casein kinase I(gamma) homolog that is preferentially expressed in the mushroom body neurons. [Neuron]

    Endogenous HMGB1 Regulates Autophagy
    Endogenous HMGB1 is a critical pro-autophagic protein that enhances cell survival and limits programmed apoptotic cell death. [J Cell Biol]

    Selective Cell Death Mediated by Small Conditional RNAs
    Results indicate that programmable mechanical transduction with small conditional RNAs represents a fundamental principle for exploring therapeutic conditional regulation in living cells. [Proc Natl Acad Sci U S A]

    Role of Symmetric and Asymmetric Division of Stem Cells in Developing Drug Resistance
    Researchers derived a previously undescribed estimate of the probability of developing drug resistance by the time a tumor is detected and calculate the expected number of resistant cancer stem cells at the time of tumor detection. [Proc Natl Acad Sci U S A]

    AggreWellVideo_645x110_v01



    POLICY

    Appeals Court Stays Stem Cell Injunction
    A federal appeals court stayed, or suspended, a preliminary injunction issued two weeks ago that brought federal funding for human embryonic stem cell research to a standstill. [Court of Appeals, United States]

    New Animal-Research Regulations for the European Union
    European scientists will use fewer animals in research when newly approved regulations come into effect across the European Union. [European Parliament, European Union]

    STEMSOFTStemLab_645x110_gif



    BUSINESS

    STEMSOFT® Software Inc. Licenses StemLab® Software to Arizona’s Celebration Stem Cell Centre
    STEMSOFT Software Inc., the leading provider of software solutions for the cell therapy and transplant community, is pleased to announce the licensing of StemLab, the leading cell therapy and cord blood banking laboratory software, to the Celebration Stem Cell Centre in Gilbert, Arizona. [STEMSOFT Software Inc. Press Release]

    Jennerex and Transgene Enter into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
    Jennerex, Inc. and Transgene announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for the treatment of solid tumors in Europe, the Commonwealth of Independent States and the Middle East. [Jennerex Inc. Press Release]

    Bristol-Myers Squibb to Acquire ZymoGenetics
    Bristol-Myers Squibb Company and ZymoGenetics, Inc. announced that the companies have signed a definitive agreement providing for the acquisition of ZymoGenetics by Bristol-Myers Squibb, for $9.75 per share in cash. [Bristol-Myers Squibb Press Release]

    Geron Obtains Exclusive License for Deriving Cartilage from Human Embryonic Stem Cells from University of Edinburgh
    Geron Corporation announced that it has entered into a worldwide, exclusive license agreement with the University of Edinburgh covering technology that allows the efficient production of chondrocytes from human pluripotent stem cells. [Geron Corporation Press Release]

    AstraZeneca and UCL Join Forces in Sight-Related Stem Cell Medicine
    AstraZeneca and University College London (UCL) have entered into a collaboration to develop regenerative medicines for diabetic retinopathy. [University College London Press Release]

    RTI Biologics and Athersys Announce Collaboration in the Orthopedic Market
    RTI Biologics Inc. (RTI) and Athersys Inc. announced an agreement under which Athersys will provide RTI access to its Multipotent Adult Progenitor Cell technologies. [Athersys Inc. Press Release]

    Anchor Therapeutics Enters Into Collaborative Research, Option and License Agreement for its Pepducin Technology
    Anchor Therapeutics announced that it has entered into a collaboration and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. with the goal of developing G protein coupled receptor-targeted therapeutic compounds utilizing Anchor's proprietary pepducin technology. [Anchor Therapeutics Press Release]

    Forbion Capital Partners Raises EUR190 Million for New Investments
    Forbion Capital Partners, a leading investment firm dedicated to the life science sector, announced the final closings of both FCF I Co-Invest Fund and of FCF II, raising a total of more than EUR190 million ($240 million). [Forbion Capital Partners Press Release]

    Cellerant Therapeutics Awarded $153 Million Contract by Biomedical Advanced Research and Development Authority to Develop Treatment for Acute Radiation Syndrome
    Cellerant Therapeutics Inc. announced that it has signed a contract valued at up to $153 million over five years with the Biomedical Advanced Research and Development Authority in the Office of the Assistant Secretary for Preparedness and Response of the Department of Health and Human Services, to develop CLT-008, a cellular therapy for the treatment of Acute Radiation Syndrome. [Cellerant Therapeutics Inc. Press Release]

    Lilly to Invest Up to $150 Million in Venture Capital
    Eli Lilly & Co., facing competition from cheaper copies of its top-selling drug next year, plans to invest as much as $150 million in three venture capital funds to aid development of new medicines. [Bloomberg]
     
    iPierian Announces Second Close of $28 Million Series B Financing
    Pierian, Inc. announced the second closing of its Series B equity financing, bringing the total amount raised in this round to $28 million. [iPierian Press Release]

    Tekmira Pharmaceuticals Receives Clearance from FDA to Initiate TKM-PLK1 Phase I Clinical Trial
    Tekmira Pharmaceuticals Corporation announced that its Investigational New Drug application for TKM-PLK1 has been cleared by the United States Food and Drug Administration (FDA) allowing Tekmira to initiate a Phase I human clinical trial. [Tekmira Pharmaceuticals Corporation Press Release]

    Kansas State Receives Patent for Noncontroversial Source of Stem Cells
    Kansas State University has been issued a patent for a plentiful and noncontroversial source of stem cells from a substance in the umbilical cord. [Kansas State University Press Release]

    Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
    Silence Therapeutics plc announced the issuance of two new patents by the United States Patent and Trademark Office which are broadly directed to double-stranded short interfering RNA sequences against the validated cancer targets epidermal growth factor receptor related protein and vascular endothelial growth factor receptor 1. [Silence Therapeutics plc Press Release]

    Genzyme Announces Agreement to Sell Genetic Testing Business to LabCorp
    Genzyme Corporation announced that it has entered into an asset purchase agreement under which Laboratory Corporation of America Holdings will acquire Genzyme Genetics for $925 million in cash. [Genzyme Corporation Press Release]

    Genetix Pharmaceuticals Renamed bluebird bio; Announces Appointment of Nick Leschly as Chief Executive Officer
    bluebird bio announced that it has changed the company name from Genetix Pharmaceuticals, Inc., to bluebird bio, Inc., effective immediately. [bluebird bio Press Release]



    NIH
     

    NIH Rushes to Hand Out Stem Cell Grants During Temporary Stay
    The National Institutes of Health (NIH) is scrambling to push out research grants for work on human embryonic stem cells (hESCs) and has given a cautious all-clear to in-house stem cell researchers after an appeals court yesterday temporarily lifted a ban on federal funding for hESC research.

    NIH Expands Network Focused on How Genes Affect Drug Responses
    The National Institutes of Health plans to spend $161.3 million over the next five years to expand the Pharmacogenomics Research Network, a nationwide collaborative of scientists focused on understanding how genes affect a person’s response to medicines.

    Funds Awarded for Disease Demonstration Studies and Technology Development
    The National Institutes of Health announced it has awarded approximately $42 million to expand the scope of eight demonstration projects designed to link changes in the human microbiome to health and disease.
     
    NIH Statement Regarding Stay of Stem Cell Injunction

    National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting (FR Doc. 2010-22327)

    National Heart, Lung, and Blood Institute; Notice of Closed Meeting (FR Doc. 2010-22314)

    National Center for Research Resources; Notice of Closed Meetings (FR Doc. 2010-22529) 

    National Institute of Mental Health Announces Availability of Funds for Competitive Revision Applications for a Repository Supporting Stem Cell Research Relevant to Mental Disorders (U24) (NOT-MH-10-032)

    Notice of Correction:  Application Due Date for RFA-HG-10-012, Revolutionary Genome Sequencing Technologies – The $1000 Genome (R01) and RFA-HG-10-013, Revolutionary Genome Sequencing Technologies – The $1000 Genome (R21) (Notice Number:NOT-HG-10-021)
     
    Knockout Mouse Production and Cryopreservation (U42) (RFA-RM-10-013)
     
    Knockout Mouse Phenotyping Project Database (U54) (RFA-RM-10-012)
     
    Knockout Mouse Phenotyping (U54) (RFA-RM-10-011)
     
    Dynamics of Host-Associated Microbial Communities (R01) (RFA-GM-12-001)
     
    Enhancing Peer Review:  Reminder of and Correction to Previous Notice on A2 Resubmission Opportunities for Eligible Applications (NOT-OD-10-135)
     
    Notice of Correction to RFA-AG-11-010, Basic Research on Self-Regulation (R21) (NOT-AG-10-011)

    Banner



    CBER

    Agenda for the Public Workshop on Cell and Gene Therapy Clinical Trials in Pediatric Populations

    Public Meeting on Animal Models–Essential Elements to Address Efficacy Under the Animal Rule; and Reopening of Comment Period [Docket No. FDA-2009-D-0007]
     
    Center for Biologics Evaluation and Research eSubmitter Pilot Evaluation Program for Blood Establishments That Collect Whole Blood and Blood Components [Docket No. FDA-2010-N-0436] 

    Complete List of Licensed Products and Establishments

    5th Assay_645x100



    REGULATORY

    FOOD AND DRUG ADMINISTRATION (United States)

    Cell and Gene Therapy Clinical Trials in Pediatric Populations; Public Workshop [Docket No. FDA-2010-N-0001]

    MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (United Kingdom)

    Variations Legislation 2010 – Details of Our Experience to Date, Submissions Audit and Update to FAQs

    Information Sent to Healthcare Professionals in August About the Safety of Medicines


    EVENTS (Listed by Date)

    Select Biosciences 7th Annual RNAi & miRNA Europe
    September 14-15, 2010
    Dublin, Ireland

    Select Biosciences Inaugural Epigenetics Europe Conference
    September 14-15, 2010
    Dublin, Ireland

    Select Biosciences Inaugural Genomics Automation Europe Conference
    September 14-15, 2010
    Dublin, Ireland

    Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010
    September 15-17, 2010
    Sydney, Australia

    First Annual BIO India International Partnering Conference
    September 21-22, 2010
    Hyderabad, India

    NEW Third Annual Maryland Stem Cell Research Symposium
    September 22, 2010
    Gaithersburg, United States

    Cellular Therapy of Cancer Symposium – ATTACK Project Meeting
    September 24-27, 2010
    Montpellier, France

    International Society for Cellular Therapy 2nd Annual Symposium on Stem Cell Translation: Best Practices & Regulatory Considerations
    September 27-28, 2010
    San Francisco, United States

    International Society for Cell and Gene Therapy of Cancer (ISCGT) Congress
    September 27-29, 2010
    Doha, Qatar

    4th American Association of Cancer Research International Conference on Molecular Diagnostics in Cancer Therapeutic Development
    September 27-30, 2010
    Denver, United States

    Select Biosciences 6th Annual Ion Channel Targets Conference
    September 28-29, 2010
    Washington, DC, United States

    Cytokines 2010: Cytokines in Infectious Diseases, Autoimmune Disorders and Cancer
    October 3-7, 2010
    Chicago, United States

    2010 World Stem Cell Summit
    October 4-6, 2010
    Detroit, United States

    9th Annual BIO Investor Forum
    October 5-6, 2010
    San Francisco, United States

    5th World Congress on Preventive & Regenerative Medicine (WCRM)
    October 5-7, 2010
    Hannover, Germany

    17th Annual Meeting German Society for Gene Therapy (DG-GT e.V.)
    October 6-9, 2010
    Munich, Germany

    COGEM Symposium: GM Viruses as Medicine: Panacea or Pandora's Box?
    October 7, 2010
    Amsterdam, The Netherlands

    American Association of Blood Banks (AABB) Annual Meeting & Cellular Therapy and Transfusion Medicine Expo (CTTXPO) 2010
    October 9-12, 2010
    Baltimore, United States

    18th Annual BioPartnering Europe
    October 10-12, 2010
    London, United Kingdom

    3rd Biobridge “Generation Regeneration” Conference
    October 11, 2010
    Geneva, Switzerland

    New York Stem Cell Foundation Fifth Annual Translational Stem Cell Research Meeting
    October 12-13, 2010
    New York, United States

    Translational Cancer Research for Basic Scientists
    October 17-22, 2010
    Boston, United States

    2010 NanoMedicine Summit
    October 18-19, 2010
    Cleveland, United States

    BIO Intellectual Property Counsels Committee Fall Conference and Committee Meeting
    October 18-20, 2010
    Boston, United States

    6th Modern Drug Discovery & Development Summit (M3D)
    October 20-22, 2010
    San Francisco, United States

    European Society of Gene and Cell Therapy (ESGCT) 18th Annual Congress
    October 22-25, 2010
    Milan, Italy

    3rd Annual Dubai Congress on Anti-Aging and Aesthetic Medicine (DCAAAM)
    October 26-27, 2010
    Dubai, United Arab Emirates

    World Stem Cells & Regenerative Medicine Congress Asia 2010
    October 26-29, 2010
    Singapore City, Singapore

    Select Biosciences 3rd Annual Molecular Diagnostics World Congress
    October 28-29, 2010
    San Diego, United States

    Fraunhofer Life Science Symposium 2010
    October 29-30, 2010
    Leipzig, Germany

    Stem Cell Society Singapore Symposium 2010: Translating Science to Therapy
    November 2-3, 2010
    Singapore City, Singapore

    BioMalaysia 2010 Conference and Exhibition
    November 2-4, 2010
    Kuala Lumpur, Malaysia

    World Cord Blood Congress
    November 4-7, 2010
    Marseille, France

    Select Biosciences 5th Annual European Biomarkers Summit
    November 9-10, 2010
    Florence, Italy

    Select Biosciences International Forum on Stem Cells
    November 12-13, 2010
    Tianjin, China

    Select Biosciences 2nd Annual RNAi Asia Conference
    November 15-16, 2010
    Singapore City, Singapore

    BIO-Europe International Partnering Conference
    November 15-17, 2010
    Munich, Germany

    9th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases
    November 17-19, 2010
    Sonoma, United States

    8th Annual Commercial Translation of Regenerative Medicine Conference
    November 18-19, 2010
    London, United Kingdom

    Stem Cell Network 10th Annual Scientific Meeting
    November 22-24, 2010
    Calgary, Canada

    HealthTech and Medicines Knowledge Transfer Network 7th Annual BioProcessUK Conference
    November 24-25, 2010
    Manchester, United Kingdom

    2nd European Association for Cardio-Thoracic Surgery (EACTS) Meeting on Cardiac and Pulmonary Regeneration
    December 2-3, 2010
    Vienna, Austria

    Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference
    December 5-8, 2010
    Orlando, United States

    Select Biosciences 5th Annual Stem Cells World Congress
    January 24-25, 2011
    San Diego, United States

    BIO Asia International Partnering Conference
    January 24-25, 2011
    Tokyo, Japan

    Phacilitate 7th Annual Cell & Gene Therapy Forum 2011
    January 24-26, 2011
    Washington DC, United States

    Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.


     

    JOB OPPORTUNITIES

    Cell Therapy Technologist (Opexa Therapeutics)

    Recruit Top Talent
    Reach more than 11,000 potential candidates by posting your organization's career opportunities with Cell Therapy News.
    Visit
    here to post your career opportunities.


    Comments or Suggestions? Email info@connexoncreative.com with your feedback.

     Learn more about Cell Therapy News:  Archives  |  Events  |  Update Profile  |  Contact Us